Melatonin in Critical Care.
Study Goal
The researchers aimed to review the principal properties of melatonin and explore its potential clinical applications for critically ill patients.
Results Summary
The study found that melatonin improves sleep quality and has analgesic, anxiolytic, antiinflammatory, and antioxidative effects. Clinical studies support its efficacy in these areas.
Population
Critically ill patients (implied, but not explicitly specified in the abstract).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
exogenous melatonin | neutral | clinical effects | - | - | demonstrated many clinical effects | #1 |
exogenous melatonin | increase | sleep quality | - | - | documented improved | #2 |
melatonin | increase | analgesic, anxiolytic, antiinflammatory, and antioxidative effects | - | - | demonstrate the analgesic, anxiolytic, antiinflammatory, and antioxidative effects | #3 |
Melatonin is involved in regulation of a variety of physiologic functions, including circadian rhythm, reproduction, mood, and immune function. Exogenous melatonin has demonstrated many clinical effects. Numerous clinical studies have documented improved sleep quality following administration of exogenous melatonin. Recent studies also demonstrate the analgesic, anxiolytic, antiinflammatory, and antioxidative effects of melatonin. This article reviews the principal properties of melatonin and how these could find clinical applications in care of the critically ill patients.